In Vitro Transcription mRNA for Efficient Cell Transfection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current non-viral gene delivery methods, such as electroporation and lipid-dependent delivery, face challenges with low efficiency and toxicity, and viral methods risk mutagenicity and immune system interactions, while mRNA transfection methods are labor-intensive and lack systematic comparison.

Innovation Solution

A method involving in vitro transcription of PCR-generated templates with specially designed primers to produce mRNA with 3′ and 5′ untranslated sequences, a 5′ cap, and a polyA tail, allowing for efficient transfection of various cells with minimal side effects and controlled gene expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If viral transduction is used to deliver nucleic acid, then transfection efficiency is improved, but risk of mutagenicity and immune system interactions increases

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidmutagenicity and immune system interactions
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and eliminates the viral vector component from the gene delivery system, using only the essential functional element (nucleic acid) without the harmful viral packaging, thereby removing mutagenicity and immune interaction risks while maintaining delivery capability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs transient mRNA transfection instead of integrated viral DNA, creating a temporary, non-permanent delivery system that achieves gene expression without permanent genetic modification, reducing long-term safety concerns

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Object-affected harmful factors

If non-viral DNA delivery methods are used, then safety is improved, but protein expression levels remain too low

Engineering Contradiction:
ImprovesafetyVSAvoidprotein expression levels
Core Design Contradiction:
Object-affected harmful factorsVSQuantity of substance

Solution Approach 1:

The patent replaces the multi-step mechanical process of DNA transfection, nuclear import, and transcription with a direct mRNA delivery system that bypasses nuclear barriers and immediately engages the translation machinery, significantly accelerating protein production

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent performs preliminary transcription in vitro to generate mature, translation-ready mRNA molecules with proper processing (capping, polyadenylation) before delivery, eliminating the need for cellular transcription machinery and enabling immediate protein expression upon entry

Inventive Principle:
Principle #10Preliminary action

3Object-affected harmful factors

If mRNA transfection is used, then permanent genetic changes are avoided, but current methods are labor-intensive

Engineering Contradiction:
Improvepermanent genetic changesVSAvoidlabor-intensive procedures
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The patent extracts the gene of interest sequence from complex cloning procedures and directly incorporates it into PCR primers, eliminating the need for bacterial transformation, plasmid isolation, and manual RNA synthesis steps

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent merges multiple separate steps (PCR amplification, in vitro transcription, and RNA purification) into a streamlined sequential process where the PCR product serves directly as the template for transcription, reducing hands-on time and procedural complexity

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves high efficiency and fidelity in mRNA synthesis, overcoming the limitations of DNA transfection by enabling transient expression without permanent genetic changes and allowing simultaneous transfection of multiple genes, particularly in cells resistant to DNA transfection.

Implementation Method 1

A method of mRNA production for use in transfection is provided that involves in vitro transcription of PCR generated templates

Methodology Applied
Scientific EffectIn vitro transcription: Enzyme

Data Source

PatentUS8859229B2Transient transfection with RNA
Publication Date: 2014.10.14 YALE UNIVERSITY
  • US8859229B2 patent drawing
  • US8859229B2 patent drawing
  • US8859229B2 patent drawing

AI summary

A method of mRNA production for use in transfection is provided, that involves in vitro transcription of PCR generated templates. This RNA can efficiently transfect different kinds of cells. This approach results in increased efficiency (fidelity and productivity) of mRNA synthesis and is less time consuming because it does not require cloning, and also consequently eliminates the unwanted errors and effects related to RNA made on DNA templates obtained with cloning techniques. The results of transfection of RNAs demonstrate that RNA transfection can be very effective in cells that are exceedingly difficult to transfect efficiently with DNA constructs. The method can be used to deliver genes into cells not- or only poorly transfectable for DNA, in vitro and in vivo.